首页 > 最新文献

Contact Dermatitis最新文献

英文 中文
Allergic cheilitis due to stannous fluoride-containing toothpaste: First case from Italy and mini-review of previously published cases 含氟锡牙膏引起的过敏性扁桃体炎:意大利首例病例及以往发表病例的小型回顾。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-30 DOI: 10.1111/cod.14625
Elena Saracco, Nicolò Rashidy, Richard Borrelli, Federico Meli, Salvatore Schinocca, Luca Lo Sardo, Iuliana Badiu, Federica Corradi, Stefania Nicola, Luisa Brussino
{"title":"Allergic cheilitis due to stannous fluoride-containing toothpaste: First case from Italy and mini-review of previously published cases","authors":"Elena Saracco, Nicolò Rashidy, Richard Borrelli, Federico Meli, Salvatore Schinocca, Luca Lo Sardo, Iuliana Badiu, Federica Corradi, Stefania Nicola, Luisa Brussino","doi":"10.1111/cod.14625","DOIUrl":"10.1111/cod.14625","url":null,"abstract":"","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An atypical case of prolonged systemic allergic dermatitis to iodinated contrast media 碘化造影剂引起的长期系统性过敏性皮炎的非典型病例。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-27 DOI: 10.1111/cod.14630
Quentin Samaran, Evangéline Clark, Anca Mirela Chiriac, Jean-Luc Bourrain, Olivier Dereure, Didier Bessis, Nadia Raison-Peyron
{"title":"An atypical case of prolonged systemic allergic dermatitis to iodinated contrast media","authors":"Quentin Samaran, Evangéline Clark, Anca Mirela Chiriac, Jean-Luc Bourrain, Olivier Dereure, Didier Bessis, Nadia Raison-Peyron","doi":"10.1111/cod.14630","DOIUrl":"10.1111/cod.14630","url":null,"abstract":"","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report of allergic contact dermatitis to benzisothiazolinone in a laundry detergent 洗衣粉中苯并异噻唑啉酮过敏性接触性皮炎病例报告。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-26 DOI: 10.1111/cod.14626
Mun Wai Lam, Tang Ngee Shim
{"title":"A case report of allergic contact dermatitis to benzisothiazolinone in a laundry detergent","authors":"Mun Wai Lam, Tang Ngee Shim","doi":"10.1111/cod.14626","DOIUrl":"10.1111/cod.14626","url":null,"abstract":"","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contact allergy to N-isopropyl-N′-phenyl paraphenylenediamine in consecutively patch tested Danish eczema patients: An observational study with historical data from 2013 to 2023 连续贴片测试的丹麦湿疹患者对 N-异丙基-N'-苯基对苯二胺的接触过敏:2013 年至 2023 年历史数据的观察性研究。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-25 DOI: 10.1111/cod.14629
Christoffer Kursawe Larsen, Mikkel Bak Jensen, Jakob F. B. Schwensen
<p><i>N</i>-isopropyl-<i>N</i>′-phenyl-paraphenylenediamine (IPPD) is used as antioxidant in industrial black rubber items such as tyres and domestic rubber products such as sport watches<span><sup>1, 2</sup></span> IPPD may cause allergic contact dermatitis known as “Volkswagen dermatitis.”<span><sup>3</sup></span> The European baseline series (EBS) contains IPPD (0.1% in pet.).<span><sup>4</sup></span> The prevalence of contact allergy (CA) to IPPD is low in many studies (<1%).<span><sup>5</sup></span> IPPD is considered a screening allergen in favour of black rubber mix (IPPD), <i>N</i>-cyclohexyl-<i>N</i>-phenyl-4-phenylenediamine (CPPD) and <i>N</i>,<i>N</i>′-diphenyl-p-phenylenediamine (DPPD) that was removed from the EBS in 1992 as CPPD and DPPD were in short supply.<span><sup>6</sup></span> Though, testing with IPPD alone may result in underdiagnosing.<span><sup>7</sup></span> New surveillance data on IPPD are needed. [Correction added on 4 September 2024, after first online publication: The heading ‘BACKGROUND’ has been removed in this version.]</p><p>The objective of this study is to investigate the epidemiology of CA to IPPD from 2013 to 2023.</p><p>An observational study using historical data from the Allergen Database at Gentofte Hospital, Denmark, was conducted. We included patients ≥18 years old being consecutively patch tested with IPPD (0.1% in pet.). at Gentofte Hospital from 2013 to 2023. Patch testing was performed and interpreted as previously.<span><sup>8</sup></span> Patients patch tested several times during our study period were likewise handled as previously.<span><sup>8</sup></span> Information on patch test results, current clinical relevance,<span><sup>8</sup></span> the MOAHLFA-index (Male/Occupational dermatitis/Atopic dermatitis/Hand dermatitis/Leg dermatitis/Facial dermatitis/Age >40), and occupation was extracted.<span><sup>8</sup></span> Time trends were assessed using the Cochrane-Armitage test for trend. Associations between IPPD CA and the MOAHLFA-index were assessed by binary logistic regressions adjusting for sex, age >40/≤40, and atopic dermatitis. Further, crude odds ratios were calculated.</p><p>As sub-analysis, patch test results on patients tested with CPPD, DPPD or <i>N</i>,<i>N</i>-di-2-naphthyl-4-phenylenediamine (all 1% in pet.) as part of the specialised rubber series from 2013 to 2023 were extracted.</p><p>A <i>p</i>-value <0.05 was considered significant. SPSS Statistics-25 and R-version-2023.12.0 were used for statistical analysis. The study is approved under the umbrella project (p-2023-14 475), <i>Region Hovedstaden - Forskningsjuras</i> internal directory of active research projects.</p><p>A total of 7575 unique patients were consecutively patch tested with IPPD from 2013 to 2023. The overall prevalence of CA to IPPD was 0.41% (31/7575) and a significantly decreasing trend was identified from 2013 to 2023 (Cochrane-Armitage <i>p</i> < 0.05) (Figure 1). The current clinical rel
N-isopropyl-N′-phenyl-paraphenylenediamine (IPPD) 被用作轮胎等工业用黑色橡胶制品和运动手表等家用橡胶制品的抗氧化剂1, 2 IPPD 可能导致过敏性接触性皮炎,即 "大众皮炎 "3。4 在许多研究中,IPPD 的接触过敏(CA)发病率很低(1%)。5 IPPD 被认为是一种筛选过敏原,而黑橡胶混合物(IPPD)、N-环己基-N-苯基-4-苯二胺(CPPD)和 N,N′-二苯基对苯二胺(DPPD)则被认为是一种筛选过敏原,由于 CPPD 和 DPPD 供不应求,1992 年已从 EBS 中删除。不过,仅用 IPPD 进行检测可能会导致诊断不足7 。[首次在线发表后,于 2024 年 9 月 4 日添加更正:本研究的目的是调查 2013 年至 2023 年期间 CA 至 IPPD 的流行病学情况。我们纳入了 2013 年至 2023 年期间在 Gentofte 医院连续接受 IPPD(宠物为 0.1%)贴片测试的年龄≥18 岁的患者。8 提取了有关斑贴试验结果、当前临床相关性、8 MOAHLFA 指数(男性/职业性皮炎/特异性皮炎/手部皮炎/腿部皮炎/面部皮炎/年龄>40)和职业的信息。8 使用 Cochrane-Armitage 趋势检验评估时间趋势。通过二元逻辑回归评估了 IPPD CA 与 MOAHLFA 指数之间的关系,并对性别、年龄>40/≤40 和特应性皮炎进行了调整。此外,还计算了粗略的几率比。作为子分析,提取了作为 2013 年至 2023 年专用橡胶系列的一部分,使用 CPPD、DPPD 或 N,N-二-2-萘基-4-苯二胺(均为宠物用 1%)对患者进行的斑贴试验结果。使用 SPSS Statistics-25 和 R-version-2023.12.0 进行统计分析。该研究在Hovedstaden - Forskningsjuras地区活跃研究项目内部目录的总括项目(p-2023-14 475)下获得批准。从2013年到2023年,共有7575名患者连续接受了IPPD贴片测试。IPPD的CA总患病率为0.41%(31/7575),从2013年到2023年呈显著下降趋势(Cochrane-Armitage p <0.05)(图1)。目前的临床相关性为20%(6/30)。IPPD CA与MOAHLFA指数中的任何变量之间均未发现显著关联(表1):患有 IPPD CA 和职业性皮炎的患者的职业是:食品业工人(n = 2);清洁工(n = 1);医护人员(n = 1);实验室工作(n = 1);仓库工作(n = 1);无业(n = 1)。在接受 CPPD、DPPD 或 N,N-二-2-萘基-4-苯二胺检测的患者中,0.76%(15/1975)对 CPPD 呈阳性反应,0.40%(8/1978)对 DPPD 呈阳性反应,0%(0/1978)对 N,N-二-2-萘基-4-苯二胺呈阳性反应。IPPD和DPPD或CPPD的联合检测显示,对IPPD产生反应的患者中,分别有92.3%(12/13)和46.2%(6/13)对CPPD或DPPD也产生反应。此外,所有对 CPPD 或 DPPD 有反应的患者也对 IPPD 有反应(表 S1 和 S2)。发现的发病率(0.41%)低于欧洲接触过敏监测系统 2019/2020 年的数据报告(0.79%)。9 尽管 IPPD CA 以前曾与职业性皮炎有关,但未发现与 MOAHLFA 指数的关联。尽管如此,考虑到 IPPD CA 患病率低、呈下降趋势、临床相关性低以及缺乏相关职业,IPPD 在 EBS 中的重要性可能会受到质疑。本研究中使用的数据来自一家专业的三级医院,仅包括重症病例。因此,在丹麦,IPPD CA可能在其他地方(如私人皮肤科医生和职业医学部门)发现。进一步的监测数据应评估 IPPD 在 EBS 中的相关性。 克里斯托弗-库尔萨维-拉森(Christoffer Kursawe Larsen):构思;方法;正式分析;调查;撰写 - 原稿。Mikkel Bak Jensen:概念化;调查;方法论;正式分析;写作 - 审阅和编辑。作者声明无利益冲突。
{"title":"Contact allergy to N-isopropyl-N′-phenyl paraphenylenediamine in consecutively patch tested Danish eczema patients: An observational study with historical data from 2013 to 2023","authors":"Christoffer Kursawe Larsen,&nbsp;Mikkel Bak Jensen,&nbsp;Jakob F. B. Schwensen","doi":"10.1111/cod.14629","DOIUrl":"10.1111/cod.14629","url":null,"abstract":"&lt;p&gt;&lt;i&gt;N&lt;/i&gt;-isopropyl-&lt;i&gt;N&lt;/i&gt;′-phenyl-paraphenylenediamine (IPPD) is used as antioxidant in industrial black rubber items such as tyres and domestic rubber products such as sport watches&lt;span&gt;&lt;sup&gt;1, 2&lt;/sup&gt;&lt;/span&gt; IPPD may cause allergic contact dermatitis known as “Volkswagen dermatitis.”&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; The European baseline series (EBS) contains IPPD (0.1% in pet.).&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; The prevalence of contact allergy (CA) to IPPD is low in many studies (&lt;1%).&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; IPPD is considered a screening allergen in favour of black rubber mix (IPPD), &lt;i&gt;N&lt;/i&gt;-cyclohexyl-&lt;i&gt;N&lt;/i&gt;-phenyl-4-phenylenediamine (CPPD) and &lt;i&gt;N&lt;/i&gt;,&lt;i&gt;N&lt;/i&gt;′-diphenyl-p-phenylenediamine (DPPD) that was removed from the EBS in 1992 as CPPD and DPPD were in short supply.&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt; Though, testing with IPPD alone may result in underdiagnosing.&lt;span&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt; New surveillance data on IPPD are needed. [Correction added on 4 September 2024, after first online publication: The heading ‘BACKGROUND’ has been removed in this version.]&lt;/p&gt;&lt;p&gt;The objective of this study is to investigate the epidemiology of CA to IPPD from 2013 to 2023.&lt;/p&gt;&lt;p&gt;An observational study using historical data from the Allergen Database at Gentofte Hospital, Denmark, was conducted. We included patients ≥18 years old being consecutively patch tested with IPPD (0.1% in pet.). at Gentofte Hospital from 2013 to 2023. Patch testing was performed and interpreted as previously.&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt; Patients patch tested several times during our study period were likewise handled as previously.&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt; Information on patch test results, current clinical relevance,&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt; the MOAHLFA-index (Male/Occupational dermatitis/Atopic dermatitis/Hand dermatitis/Leg dermatitis/Facial dermatitis/Age &gt;40), and occupation was extracted.&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt; Time trends were assessed using the Cochrane-Armitage test for trend. Associations between IPPD CA and the MOAHLFA-index were assessed by binary logistic regressions adjusting for sex, age &gt;40/≤40, and atopic dermatitis. Further, crude odds ratios were calculated.&lt;/p&gt;&lt;p&gt;As sub-analysis, patch test results on patients tested with CPPD, DPPD or &lt;i&gt;N&lt;/i&gt;,&lt;i&gt;N&lt;/i&gt;-di-2-naphthyl-4-phenylenediamine (all 1% in pet.) as part of the specialised rubber series from 2013 to 2023 were extracted.&lt;/p&gt;&lt;p&gt;A &lt;i&gt;p&lt;/i&gt;-value &lt;0.05 was considered significant. SPSS Statistics-25 and R-version-2023.12.0 were used for statistical analysis. The study is approved under the umbrella project (p-2023-14 475), &lt;i&gt;Region Hovedstaden - Forskningsjuras&lt;/i&gt; internal directory of active research projects.&lt;/p&gt;&lt;p&gt;A total of 7575 unique patients were consecutively patch tested with IPPD from 2013 to 2023. The overall prevalence of CA to IPPD was 0.41% (31/7575) and a significantly decreasing trend was identified from 2013 to 2023 (Cochrane-Armitage &lt;i&gt;p&lt;/i&gt; &lt; 0.05) (Figure 1). The current clinical rel","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cod.14629","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potassium dichromate sensitivity presenting as tefillin dermatitis: A retrospective cohort study 重铬酸钾敏感表现为特非林皮炎:一项回顾性队列研究。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-24 DOI: 10.1111/cod.14627
Daniel Hilewitz, Akiva Trattner, Yehonatan Noyman, Daniel Mimouni, Igor Snast

Background

Tefillin are a religious article worn by Jewish men during daily prayer. Tefillin dermatitis secondary to potassium dichromate sensitivity is recognised, but data remain sparse.

Objective

To investigate the prevalence and clinical characteristics of tefillin dermatitis.

Methods

Patients who underwent patch testing with the European baseline series in a tertiary dermatology clinic in 2009–2023 and were diagnosed with tefillin dermatitis were identified by file review and their clinical data recorded.

Results

Of 1679 consecutive male patients tested, 25 (1.49%) were diagnosed with tefillin dermatitis, accounting for 15.34% of all potassium-dichromate-positive patients (163/1679). Mean pre-symptomatic duration of tefillin use was 38 ± 16.9 years, and mean follow-up time, 3.1 ± 2.9 years. Patients presented with an eczematous rash on body areas in direct contact with the leather box or straps of the tefillin. An id reaction was noted in 32%, and sensitivity to other leather accessories, in 44%. Fourteen patients (56%) switched to chromate-free tefillin: symptoms resolved completely in 11 (79%) and partially in 2.

Limitations

Retrospective cohort design.

Conclusion

This is the largest study to date of tefillin dermatitis caused by sensitivity to potassium dichromate used in leather production. Prognosis after switching to chromate-free tefillin was good-to-excellent. Tefillin dermatitis may be more prevalent than previously thought.

背景介绍特非林是犹太男子在日常祈祷时佩戴的宗教用品。由于对重铬酸钾敏感而继发的特非林皮炎已得到认可,但相关数据仍然很少:目的:调查特菲林皮炎的发病率和临床特征:方法:在一家三级皮肤病诊所对 2009-2023 年期间接受欧洲基线系列贴片测试并被诊断为特非林皮炎的患者进行档案审查,并记录他们的临床数据:在连续接受检测的 1679 名男性患者中,有 25 人(1.49%)被诊断为特非林皮炎,占所有重铬酸钾阳性患者(163/1679)的 15.34%。症状出现前使用特非林的平均时间为 38 ± 16.9 年,平均随访时间为 3.1 ± 2.9 年。患者在直接接触到皮盒或皮带的身体部位出现湿疹。32%的患者出现了id反应,44%的患者对其他皮革配件敏感。14名患者(56%)改用不含铬酸盐的德非林:11名患者(79%)的症状完全缓解,2名患者的症状部分缓解:局限性:回顾性队列设计:这是迄今为止关于因对皮革生产过程中使用的重铬酸钾敏感而引起的tefillin皮炎的最大规模研究。改用不含铬酸盐的特菲林后,预后良好。茶具皮炎的发病率可能比以前想象的要高。
{"title":"Potassium dichromate sensitivity presenting as tefillin dermatitis: A retrospective cohort study","authors":"Daniel Hilewitz,&nbsp;Akiva Trattner,&nbsp;Yehonatan Noyman,&nbsp;Daniel Mimouni,&nbsp;Igor Snast","doi":"10.1111/cod.14627","DOIUrl":"10.1111/cod.14627","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Tefillin are a religious article worn by Jewish men during daily prayer. Tefillin dermatitis secondary to potassium dichromate sensitivity is recognised, but data remain sparse.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To investigate the prevalence and clinical characteristics of tefillin dermatitis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Patients who underwent patch testing with the European baseline series in a tertiary dermatology clinic in 2009–2023 and were diagnosed with tefillin dermatitis were identified by file review and their clinical data recorded.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 1679 consecutive male patients tested, 25 (1.49%) were diagnosed with tefillin dermatitis, accounting for 15.34% of all potassium-dichromate-positive patients (163/1679). Mean pre-symptomatic duration of tefillin use was 38 ± 16.9 years, and mean follow-up time, 3.1 ± 2.9 years. Patients presented with an eczematous rash on body areas in direct contact with the leather box or straps of the tefillin. An id reaction was noted in 32%, and sensitivity to other leather accessories, in 44%. Fourteen patients (56%) switched to chromate-free tefillin: symptoms resolved completely in 11 (79%) and partially in 2.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Limitations</h3>\u0000 \u0000 <p>Retrospective cohort design.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This is the largest study to date of tefillin dermatitis caused by sensitivity to potassium dichromate used in leather production. Prognosis after switching to chromate-free tefillin was good-to-excellent. Tefillin dermatitis may be more prevalent than previously thought.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cod.14627","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A genome-wide association study of hand eczema identifies locus 20q13.33 and reveals genetic overlap with atopic dermatitis 手部湿疹的全基因组关联研究确定了 20q13.33 位点,并揭示了与特应性皮炎的遗传重叠。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-24 DOI: 10.1111/cod.14619
Fieke M. Rosenberg, Peter J. van der Most, Laura Loman, Zoha Kamali, Daan Dittmar, Harold Snieder, Marie L. A. Schuttelaar

Background

Twin studies revealed that genetic effects play a role in hand eczema (HE), but the responsible genetic factors are unknown.

Objectives

To identify and characterise genetic loci associated with HE and to provide insight into the genetic overlap between HE and atopic dermatitis (AD).

Methods

We used questionnaire-derived and genotype data from the European population-based Lifelines cohort and biobank. We performed a discovery genome-wide association study (GWAS) of HE (2879 cases and 16 249 controls) and of AD (1706 cases and 17 190 controls). We replicated our findings in an independent Lifelines sample for HE (1188 cases and 6431 controls) and AD (757 cases and 6747 controls). We conducted several post-GWAS analyses and performed genetic correlation analyses between our HE results and independent AD data.

Results

The two-step GWAS of HE, regardless of adjusting for AD, identified one independent locus 20q13.33, likely driven by a number of causal single-nucleotide polymorphisms. For the AD GWAS, we replicated a known stop-gained rs61816761 at locus 1q21.3 (FLG, FLGAS1). We found a strong genetic correlation (p < 0.01) between HE and AD (rg = 0.65), regardless of adjusting for AD (rg = 0.63).

Conclusions

Locus 20q13.33 is associated with HE, and there is a large genetic overlap between HE and AD.

背景:双生子研究显示,遗传效应在手湿疹(HE)中起着一定作用,但导致手湿疹的遗传因素尚不清楚:目的:确定与手部湿疹相关的遗传位点并描述其特征,同时深入了解手部湿疹与特应性皮炎(AD)之间的遗传重叠:方法:我们使用了来自欧洲人群生命线队列和生物库的问卷调查数据和基因型数据。我们对 HE(2879 例病例和 16 249 例对照)和 AD(1706 例病例和 17 190 例对照)进行了发现性全基因组关联研究(GWAS)。我们在独立的生命线样本中对 HE(1188 例病例和 6431 例对照)和 AD(757 例病例和 6747 例对照)重复了我们的研究结果。我们进行了多项 GWAS 后分析,并对 HE 结果和独立的 AD 数据进行了遗传相关性分析:结果: HE 的两步 GWAS,无论是否对 AD 进行调整,都确定了一个独立的基因位点 20q13.33,该位点很可能是由一些致病单核苷酸多态性驱动的。在 AD 的 GWAS 中,我们复制了 1q21.3 位点(FLG,FLGAS1)上的一个已知的停止增益 rs61816761。我们发现,无论是否对注意力缺失症进行调整(rg = 0.63),都存在很强的遗传相关性(p g = 0.65):结论:20q13.33位点与HE相关,HE和AD之间存在大量遗传重叠。
{"title":"A genome-wide association study of hand eczema identifies locus 20q13.33 and reveals genetic overlap with atopic dermatitis","authors":"Fieke M. Rosenberg,&nbsp;Peter J. van der Most,&nbsp;Laura Loman,&nbsp;Zoha Kamali,&nbsp;Daan Dittmar,&nbsp;Harold Snieder,&nbsp;Marie L. A. Schuttelaar","doi":"10.1111/cod.14619","DOIUrl":"10.1111/cod.14619","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Twin studies revealed that genetic effects play a role in hand eczema (HE), but the responsible genetic factors are unknown.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To identify and characterise genetic loci associated with HE and to provide insight into the genetic overlap between HE and atopic dermatitis (AD).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We used questionnaire-derived and genotype data from the European population-based Lifelines cohort and biobank. We performed a discovery genome-wide association study (GWAS) of HE (2879 cases and 16 249 controls) and of AD (1706 cases and 17 190 controls). We replicated our findings in an independent Lifelines sample for HE (1188 cases and 6431 controls) and AD (757 cases and 6747 controls). We conducted several post-GWAS analyses and performed genetic correlation analyses between our HE results and independent AD data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The two-step GWAS of HE, regardless of adjusting for AD, identified one independent locus 20q13.33, likely driven by a number of causal single-nucleotide polymorphisms. For the AD GWAS, we replicated a known stop-gained rs61816761 at locus 1q21.3 (<i>FLG</i>, <i>FLGAS1</i>). We found a strong genetic correlation (<i>p</i> &lt; 0.01) between HE and AD (<i>r</i><sub>g</sub> = 0.65), regardless of adjusting for AD (<i>r</i><sub>g</sub> = 0.63).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Locus 20q13.33 is associated with HE, and there is a large genetic overlap between HE and AD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cod.14619","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed hypersensitivity reaction to testosterone cypionate injections 注射环戊丙酸睾酮后出现迟发性超敏反应。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-24 DOI: 10.1111/cod.14624
Mayra Betancourt Ponce, Eric Schauberger, Ellen Connor, Margo Reeder
<p>Testicular hypergonadotropic hypogonadism is a disorder characterised by insufficient or absent production of testosterone by the testes in the absence of a hypothalamic or pituitary problem causing delayed or absent puberty. Injections are initially the preferred route of administration of testosterone for puberty induction due to their ability to titrate the small initial doses that are appropriate for puberty induction.<span><sup>1</sup></span></p><p>A 13-year-old male with a history of testicular hypergonadotropic hypogonadism presented to our clinic, reporting a red, itchy rash at the site of his weekly subcutaneous 26 mg dose of testosterone cypionate (200 mg/mL). His first injection was unremarkable; however, a few weeks later, he started developing swelling and pruritic papules at the injection site. The rash developed 8–12 h following injection, lasting 5–7 days before resolution (Figure 1A). Skin prick and intradermal allergy testing for testosterone cypionate (200 mg/mL) were initially negative at their 15-min readings, but the patient developed a delayed positive reaction to the intradermal test the following day (Figure 1B). Patch testing of the excipients, including benzyl benzoate, benzyl alcohol and cottonseed oil, was negative. After switching to testosterone enanthate, the patient was able to resume testosterone therapy.</p><p>Testosterone injections are a common and safe hormone replacement strategy used in different clinical settings, including primary and acquired hypogonadism<span><sup>2</sup></span> and masculinising hormone therapy in transgender individuals.<span><sup>3</sup></span> Short-acting testosterone cypionate and enanthate injections have proven efficacious for puberty induction and are the most used formulations for this purpose.<span><sup>4</sup></span></p><p>Allergic contact dermatitis (ACD) to testosterone is rare and only two cases have been reported.<span><sup>5, 6</sup></span> In these cases, patients raised suspicion of testosterone ACD following reactions to Andropatch® placement and were patch-tested to different testosterone formulations and Andropatch® excipients, including ethanol. Results showed positive reactions to testosterone propionate and undecanoate<span><sup>5</sup></span> in one case and to testosterone enanthate and undecanoate in the other.<span><sup>6</sup></span> To our knowledge, this is the first reported case of a delayed-type hypersensitivity reaction to testosterone cypionate.</p><p>ACD to excipients in injectable testosterone preparations has not been reported. A case of anaphylaxis secondary to benzyl benzoate in testosterone injections was described,<span><sup>7</sup></span> but our patient did not have an immediate reaction and instead developed delayed reactions, consistent with Type IV rather than Type I hypersensitivity reaction. With injections being a common route of administration of testosterone, clinicians should be aware of the rare setting of delayed hypersensitivi
睾丸高促性腺激素性腺功能减退症是一种疾病,其特征是在没有下丘脑或垂体问题的情况下,睾丸产生的睾酮不足或缺乏,导致青春期延迟或缺失。注射是诱导青春期的首选睾酮给药途径,因为它能够滴定适合诱导青春期的小剂量初始剂量。1A 13 岁男性,有睾丸性腺功能减退症病史,来我院就诊时报告说,他每周皮下注射 26 毫克环戊丙酸睾酮(200 毫克/毫升)的部位出现红色痒疹。他第一次注射时并无异常,但几周后,注射部位开始出现肿胀和瘙痒性丘疹。皮疹在注射后 8-12 小时出现,持续 5-7 天后消退(图 1A)。对环戊丙酸睾酮(200 毫克/毫升)的皮肤点刺试验和皮内过敏试验最初在 15 分钟读数时均为阴性,但患者在第二天的皮内试验中出现了延迟阳性反应(图 1B)。对辅料(包括苯甲酸苄酯、苯甲醇和棉籽油)的斑贴试验结果均为阴性。3 短效环戊丙酸睾酮和庚酸睾酮注射剂已被证明对青春期诱导具有疗效,也是目前最常用的睾酮制剂。对睾酮的过敏性接触性皮炎(ACD)很少见,仅有两例报道。5, 6 在这些病例中,患者在使用安多帕®后出现反应,怀疑是睾酮过敏性接触性皮炎,并对不同的睾酮制剂和安多帕®辅料(包括乙醇)进行了贴敷试验。结果显示,一例患者对丙酸睾酮和十一酸睾酮5 呈阳性反应,另一例患者对庚酸睾酮和十一酸睾酮呈阳性反应6。据我们所知,这是第一例报告的对环戊丙酸睾酮的迟发型超敏反应。注射用睾酮制剂中的辅料导致过敏性休克的病例尚未见报道。曾有一例睾酮注射剂中的苯甲酸苄酯继发过敏性休克的病例,7 但我们的患者没有立即出现反应,而是出现了延迟反应,符合 IV 型而非 I 型超敏反应。注射是睾酮的常见给药途径,临床医生应注意对环戊丙酸睾酮(主要配方之一)迟发性过敏的罕见情况。在对环戊丙酸睾酮过敏的情况下,可以考虑使用其他注射制剂。 Mayra Betancourt Ponce:写作--原稿;写作--审阅和编辑。Eric Schauberger:调查;方法;验证。Ellen Connor:调查;方法;验证。马戈-里德作者声明无利益冲突。
{"title":"Delayed hypersensitivity reaction to testosterone cypionate injections","authors":"Mayra Betancourt Ponce,&nbsp;Eric Schauberger,&nbsp;Ellen Connor,&nbsp;Margo Reeder","doi":"10.1111/cod.14624","DOIUrl":"10.1111/cod.14624","url":null,"abstract":"&lt;p&gt;Testicular hypergonadotropic hypogonadism is a disorder characterised by insufficient or absent production of testosterone by the testes in the absence of a hypothalamic or pituitary problem causing delayed or absent puberty. Injections are initially the preferred route of administration of testosterone for puberty induction due to their ability to titrate the small initial doses that are appropriate for puberty induction.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;A 13-year-old male with a history of testicular hypergonadotropic hypogonadism presented to our clinic, reporting a red, itchy rash at the site of his weekly subcutaneous 26 mg dose of testosterone cypionate (200 mg/mL). His first injection was unremarkable; however, a few weeks later, he started developing swelling and pruritic papules at the injection site. The rash developed 8–12 h following injection, lasting 5–7 days before resolution (Figure 1A). Skin prick and intradermal allergy testing for testosterone cypionate (200 mg/mL) were initially negative at their 15-min readings, but the patient developed a delayed positive reaction to the intradermal test the following day (Figure 1B). Patch testing of the excipients, including benzyl benzoate, benzyl alcohol and cottonseed oil, was negative. After switching to testosterone enanthate, the patient was able to resume testosterone therapy.&lt;/p&gt;&lt;p&gt;Testosterone injections are a common and safe hormone replacement strategy used in different clinical settings, including primary and acquired hypogonadism&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; and masculinising hormone therapy in transgender individuals.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; Short-acting testosterone cypionate and enanthate injections have proven efficacious for puberty induction and are the most used formulations for this purpose.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Allergic contact dermatitis (ACD) to testosterone is rare and only two cases have been reported.&lt;span&gt;&lt;sup&gt;5, 6&lt;/sup&gt;&lt;/span&gt; In these cases, patients raised suspicion of testosterone ACD following reactions to Andropatch® placement and were patch-tested to different testosterone formulations and Andropatch® excipients, including ethanol. Results showed positive reactions to testosterone propionate and undecanoate&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; in one case and to testosterone enanthate and undecanoate in the other.&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt; To our knowledge, this is the first reported case of a delayed-type hypersensitivity reaction to testosterone cypionate.&lt;/p&gt;&lt;p&gt;ACD to excipients in injectable testosterone preparations has not been reported. A case of anaphylaxis secondary to benzyl benzoate in testosterone injections was described,&lt;span&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt; but our patient did not have an immediate reaction and instead developed delayed reactions, consistent with Type IV rather than Type I hypersensitivity reaction. With injections being a common route of administration of testosterone, clinicians should be aware of the rare setting of delayed hypersensitivi","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cod.14624","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of fixed drug eruption caused by allylisopropylacetylurea and bromovalerylurea in the same lesion 一例由烯丙基异丙基乙酰脲和溴戊酰脲引起的固定药物疹。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-24 DOI: 10.1111/cod.14622
Yuriko Ishikawa, Kanako Akashi, Saki Ueda, Ken Washio
{"title":"A case of fixed drug eruption caused by allylisopropylacetylurea and bromovalerylurea in the same lesion","authors":"Yuriko Ishikawa,&nbsp;Kanako Akashi,&nbsp;Saki Ueda,&nbsp;Ken Washio","doi":"10.1111/cod.14622","DOIUrl":"10.1111/cod.14622","url":null,"abstract":"","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of allergic contact dermatitis due to implantable cardioverter-defibrillator 一例植入式心律转复除颤器引起的过敏性接触性皮炎病例
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-21 DOI: 10.1111/cod.14623
Luca Potestio, Cataldo Patruno, Diego Colonna, Gioacchino Lucagnano, Annalisa Passariello, Pasqualina Ruggiero, Maria Giovanna Russo, Maddalena Napolitano
{"title":"A case of allergic contact dermatitis due to implantable cardioverter-defibrillator","authors":"Luca Potestio,&nbsp;Cataldo Patruno,&nbsp;Diego Colonna,&nbsp;Gioacchino Lucagnano,&nbsp;Annalisa Passariello,&nbsp;Pasqualina Ruggiero,&nbsp;Maria Giovanna Russo,&nbsp;Maddalena Napolitano","doi":"10.1111/cod.14623","DOIUrl":"10.1111/cod.14623","url":null,"abstract":"","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141551565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The correlation between self-reported hand eczema and clinically based diagnosis in professional cleaners 专业清洁工自我报告的手部湿疹与临床诊断之间的相关性。
IF 4.8 1区 医学 Q2 ALLERGY Pub Date : 2024-06-06 DOI: 10.1111/cod.14611
Farnam Barati Sedeh, Anna Glenn Ullum, Thórunn Elísabet Michaelsdóttir, Karl Bang Christensen, Sarah Gharabaghi Stückler, Gregor Borut Ernst Jemec, Ole Steen Mortensen, Kristina Sophie Ibler

Background

Most studies investigating the prevalence of hand eczema (HE) in professional cleaners use self-reported questionnaire-based data. However, no validation studies of self-reporting of HE among professional cleaners have previously been conducted.

Objectives

To investigate (1) the point prevalence of self-reported HE, (2) the point prevalence of HE estimated by physical examination of the hands and (3) the sensitivity and specificity of self-reporting of HE compared with the diagnosis based on physical examination among professional cleaners.

Methods

Professional cleaners at three different hospitals in Region Zealand were invited to fill out a questionnaire. The point prevalence of self-reported HE was estimated based on questions from the Nordic Occupational Skin Questionnaire. After completing the questionnaire, each cleaner underwent a physical examination of the hands by a dermatologist on the same day.

Results

In total, 234 cleaners were invited to participate in the study, and 224 (response rate = 96.0%) agreed to take part. Based on the self-reported questionnaires, 5.3% (n = 12) of the cleaners had current HE. Based on an examination by a physician, 19.2% (n = 43) of the cleaners had current HE. The sensitivity of self-reported HE was found to be 28.0%, while the specificity was found to be 100.0%. The positive predictive value was found to be 100.0%, while the negative predictive value was 85.0%.

Conclusion

The true point prevalence of HE among professional cleaners is underestimated when based on self-reporting.

背景:大多数调查职业清洁工手部湿疹(HE)患病率的研究都使用自我报告的问卷数据。然而,此前尚未对专业清洁人员自我报告的手部湿疹情况进行过验证研究:调查 (1) 自我报告的 HE 点患病率;(2) 通过手部物理检查估计的 HE 点患病率;(3) 与基于物理检查的诊断相比,职业清洁工自我报告 HE 的敏感性和特异性:方法:邀请新西兰地区三家不同医院的专业清洁工填写调查问卷。根据北欧职业皮肤问卷中的问题估算出自我报告的 HE 点流行率。填写完问卷后,每位清洁工在同一天接受了皮肤科医生的手部体检:共有 234 名清洁工受邀参加研究,其中 224 人(回复率 = 96.0%)同意参加。根据自我报告的调查问卷,5.3%(n = 12)的清洁工目前患有高血压。根据医生的检查结果,19.2%(n = 43)的清洁工目前患有高血压。自我报告 HE 的敏感性为 28.0%,特异性为 100.0%。阳性预测值为 100.0%,阴性预测值为 85.0%:结论:如果以自我报告为基础,则会低估专业清洁人员中高血压的真实发病率。
{"title":"The correlation between self-reported hand eczema and clinically based diagnosis in professional cleaners","authors":"Farnam Barati Sedeh,&nbsp;Anna Glenn Ullum,&nbsp;Thórunn Elísabet Michaelsdóttir,&nbsp;Karl Bang Christensen,&nbsp;Sarah Gharabaghi Stückler,&nbsp;Gregor Borut Ernst Jemec,&nbsp;Ole Steen Mortensen,&nbsp;Kristina Sophie Ibler","doi":"10.1111/cod.14611","DOIUrl":"10.1111/cod.14611","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Most studies investigating the prevalence of hand eczema (HE) in professional cleaners use self-reported questionnaire-based data. However, no validation studies of self-reporting of HE among professional cleaners have previously been conducted.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To investigate (1) the point prevalence of self-reported HE, (2) the point prevalence of HE estimated by physical examination of the hands and (3) the sensitivity and specificity of self-reporting of HE compared with the diagnosis based on physical examination among professional cleaners.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Professional cleaners at three different hospitals in Region Zealand were invited to fill out a questionnaire. The point prevalence of self-reported HE was estimated based on questions from the Nordic Occupational Skin Questionnaire. After completing the questionnaire, each cleaner underwent a physical examination of the hands by a dermatologist on the same day.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total, 234 cleaners were invited to participate in the study, and 224 (response rate = 96.0%) agreed to take part. Based on the self-reported questionnaires, 5.3% (<i>n</i> = 12) of the cleaners had current HE. Based on an examination by a physician, 19.2% (<i>n</i> = 43) of the cleaners had current HE. The sensitivity of self-reported HE was found to be 28.0%, while the specificity was found to be 100.0%. The positive predictive value was found to be 100.0%, while the negative predictive value was 85.0%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The true point prevalence of HE among professional cleaners is underestimated when based on self-reporting.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10527,"journal":{"name":"Contact Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cod.14611","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contact Dermatitis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1